Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 71335-9699 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - lbl713359699

Label - lbl713359699

This is a description of Pregabalin Capsules, a medication distributed by Bryant Ranch Prepack, Inc. Each capsule contains 200mg Pregabalin, and caution should be taken to keep medication away from children. It should be stored at room temperature, and dispensed in child-resistant containers. Further medication guide information is available through the provided link. Information on the manufacturer, ScieGen Pharmaceuticals, Inc. is also included.*

Figure 1 - pregabalin fig01

Figure 1 - pregabalin fig01

The text contains data on the percentage of patients improved and the percentage improvement in pain from baseline, but it is difficult to interpret due to the formation and symbols present.*

Figure 2 - pregabalin fig02

Figure 2 - pregabalin fig02

This is a description of the improvement observed in patients receiving Pregabalin 160mg for 3 days. It shows the percentage of patients improved in pain from baseline, with values of 100%, 2%, and 10% reported. There is also a table with some numerical values that is not clearly related to the main information.*

Figure 3 - pregabalin fig03

Figure 3 - pregabalin fig03

The text is not available.*

Figure 4 - pregabalin fig04

Figure 4 - pregabalin fig04

Figure 5 - pregabalin fig05

Figure 5 - pregabalin fig05

This appears to be a table showing the dosages and results of a study comparing the pain relief effectiveness of Fregabalin, Pregataiin, and a placebo. The table shows the dosage frequency for each treatment, and a chart displaying how many patients saw improvement with each treatment. It also includes a percentage improvement chart in pain for each treatment.*

Figure 6 - pregabalin fig06

Figure 6 - pregabalin fig06

Figure 7 - pregabalin fig07

Figure 7 - pregabalin fig07

Figure 9 - pregabalin fig08

Figure 9 - pregabalin fig08

The text displays a chart showing the percentage of patients who improved while taking Pregabalin at different daily doses and a placebo. The percentage of improvement is measured in pain reduction from baseline. The chart shows that Pregabalin at 300mg and 450mg daily doses improved the condition in a higher percentage of patients compared to those who took a placebo. No further information is available.*

Figure 10 - pregabalin fig09

Figure 10 - pregabalin fig09

Figure 11 - pregabalin fig10

Figure 11 - pregabalin fig10

Figure 12 - pregabalin fig11

Figure 12 - pregabalin fig11

The text seems to be a chart or a table that shows the percent improvement of subjects in a study. The study is likely comparing the efficacy of two treatments, Pregabalin and Placebo, over 16 weeks. The percent improvement ranges from 100 to 280 and is measured at various points from 210 to 270. However, without more context, it is not possible to provide a conclusive description of the data.*

Cockcroft and Gault equation - pregabalin formula

Cockcroft and Gault equation - pregabalin formula

This is a formula used to calculate creatinine clearance (CLCT), which is an estimate of kidney function. It involves multiplying 140 minus the patient's age (in years) by their weight (in kilograms), then multiplying that result by 0.85 for female patients. The final step is to multiply that result by the patient's serum creatinine level (in milligrams per deciliter), divided by 72.*

Chemical Structure - pregabalin str

Chemical Structure - pregabalin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.